Swedish Orphan Biovitrum AB (publ) : Invitation - Presentation of Sobi's first quarter results 2013 On April 26, at 08:00 CET, Swedish Orphan Biovitrum AB (Sobi) will publish its interim report for the first quarter, 2013. Financial analysts and media are invited to participate in a telephone conference, which will include a presentation of the results, at 14:00 CET. The event will be hosted by Sobi's CEO and President, Geoffrey McDonough, and the presentation will be held in English. The presentation can be followed live or afterwards on our website, www.sobi.com. Slides used in the presentation will be made available on our website prior to the telephone conference. To participate in the telephone conference, please call: SE: +46 8 5199 9366 US: +1877788 9023 UK: +44207660 2078 Audience URL: https://www.anywhereconference.com/?Conference=137346811&PIN=479968 --- About Sobi Sobi is an international specialty healthcare company dedicated to rare diseases. Our mission is to develop and deliver innovative therapies and services to improve the lives of patients. The product portfolio is primarily focused on inflammation and genetic diseases, with three late stage biological development projects within hemophilia and neonatology. We also market a portfolio of specialty and rare disease products for partner companies. Sobi is a pioneer in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing. In 2012, Sobi had total revenues of SEK 1.9 billion (€ 215 M) and about 480 employees. The share (STO: SOBI) is listed on NASDAQ OMX Stockholm. More information is available at www.sobi.com For more information - not for publication Media relations Investor relations Oskar Bosson, Head of Jörgen Winroth, Vice President, Head of Investor Communications Relations T: +46 70410 71 80 T: +46 8 697 20 00 firstname.lastname@example.org email@example.com Sobi press release April 17, 2013 in pdf version ------------------------------------------------------------------------------ This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Swedish Orphan Biovitrum AB (publ) via Thomson Reuters ONE HUG#1693436
Swedish Orphan Biovitrum AB (publ) : Invitation - Presentation of Sobi's first quarter results 2013
Press spacebar to pause and continue. Press esc to stop.